Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Independent Wellness vs NowPatient

Independent Wellness
Graded #152

Higher grade

vs+2.700000000000003
NowPatient
Graded #217

Lower grade

The verdict

Independent Wellness takes it — 68.2/100 to 65.5/100.

Independent Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth wellness clinic offering GLP-1 medications on a 4-week billing cycle.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIndependent Wellness +19
54
35
Dose & formulationNowPatient +21
72
93
Clinical oversightNowPatient +4
82
86
Labs & monitoringIndependent Wellness +11
65
54
FulfillmentIndependent Wellness +11
81
70
Contract termsEven
55
55
Independent Wellness · left barNowPatient · right bar

The numbers

MetricIndependent WellnessNowPatient
WeighScore68.2/10065.5/100
GradeCC
Scorecard rank#152#217
Semaglutide$249/mo (all doses, compounded)$1,349/mo (brand Wegovy)
Tirzepatide$379/mo (all doses, compounded)$1,069/mo (brand Mounjaro, promotional rate)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Independent Wellness

Graded #152 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard